Your browser doesn't support javascript.
loading
Considering gemcitabine-based combination chemotherapy as a potential treatment for advanced oesophageal cancer: A meta-analysis of randomised trials.
Yang, Jian; Liang, Xiao; Zhai, Yuanfang; Hu, Xiaoling; Jia, Zhiwu; Cheng, Xiaolong.
Afiliación
  • Yang J; Translational Medicine Research Center, Shanxi Medical University, Taiyuan, PR China.
  • Liang X; Department of Pathology & Shanxi Key Laboratory of Carcinogenesis and Translational Research on Esophageal Cancer, Shanxi Medical University, Taiyuan, PR China.
  • Zhai Y; Department of Pathology & Shanxi Key Laboratory of Carcinogenesis and Translational Research on Esophageal Cancer, Shanxi Medical University, Taiyuan, PR China.
  • Hu X; Department of Anatomy, Shanxi Medical University, Taiyuan, PR China.
  • Jia Z; Department of Pathology & Shanxi Key Laboratory of Carcinogenesis and Translational Research on Esophageal Cancer, Shanxi Medical University, Taiyuan, PR China.
  • Cheng X; Department of Anatomy, Shanxi Medical University, Taiyuan, PR China.
Int J Clin Pract ; 74(7): e13510, 2020 Jul.
Article en En | MEDLINE | ID: mdl-32279393
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Esofágicas / Desoxicitidina / Recurrencia Local de Neoplasia / Antimetabolitos Antineoplásicos Tipo de estudio: Clinical_trials / Systematic_reviews Límite: Female / Humans Idioma: En Año: 2020 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Esofágicas / Desoxicitidina / Recurrencia Local de Neoplasia / Antimetabolitos Antineoplásicos Tipo de estudio: Clinical_trials / Systematic_reviews Límite: Female / Humans Idioma: En Año: 2020 Tipo del documento: Article